Navigation Links
Uroplasty to Present at the Canaccord Genuity 6th Annual Cardiovascular, Aesthetics & Metabolic Disorders Medical Device Conference
Date:11/30/2011

MINNEAPOLIS, Nov. 30, 2011 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, announced today that David Kaysen, President and CEO, and Medi Jiwani, Vice President and CFO, will present the Company's business strategy and financial results at the Canaccord Genuity 6th Annual Cardiovascular, Aesthetics & Metabolic Disorders Medical Device Conference at 4:00 PM PT on Tuesday, December 6, 2011 at The St. Regis Hotel in San Francisco.

Attendance at the conference is by invitation only.  A live audio webcast of the presentation will be broadcast via the Internet.  Those interested in listening to the webcast may access it at http://www.newswire.ca/en/webcast/viewEvent.cgi?eventID=3742860, or through Uroplasty's website at www.uroplasty.com. An archived replay of the presentation will be available for 90 days.

About Uroplasty, Inc.

Uroplasty, Inc., headquartered in Minnetonka, Minnesota, with wholly-owned subsidiaries in The Netherlands and the United Kingdom, is a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions. Our focus is the continued commercialization of our Urgent® PC Neuromodulation System, the only FDA-cleared neuromodulation system that delivers posterior tibial nerve stimulation (PTNS) for the office-based treatment of overactive bladder and associated symptoms of urgency, frequency and urge incontinence. We also offer Macroplastique® Implants, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence primarily due to int
'/>"/>

SOURCE Uroplasty, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Uroplasty Announces Issuance of New Apparatus Patent for the Urgent® PC Neuromodulation System Stimulator
2. Uroplasty Reports Fiscal Second Quarter 2012 Financial Results
3. Uroplasty to Issue Second Quarter 2012 Financial Results on October 27, 2011
4. Uroplasty to Present at the 6th Annual JMP Securities Healthcare Conference
5. Uroplasty Reports Financial Results for the First Quarter of Fiscal 2012
6. Uroplasty to Issue First Quarter 2012 Financial Results on July 28, 2011
7. Two Additional Private Payers Provide Coverage for Posterior Tibial Nerve Stimulation Delivered Using the Uroplasty Urgent® PC Neuromodulation System
8. Uroplasty on Preliminary List of Additions to Russell 3000® and Russell Global® Indexes
9. Uroplastys Dave Kaysen to Ring NASDAQ Closing Bell
10. Uroplasty Reports Financial Results for the Fiscal Fourth Quarter and Full Year 2011
11. Uroplasty to Present at the JMP Securities Research Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... and MECHELEN, Belgium , May ... AbbVie (NYSE: ABBV ) announced today an ... Crohn,s disease.  Galapagos will fund and complete a Phase ... facilitate rapid progression into Phase 3.  Upon successful completion ... pay Galapagos $50 million.  The terms of the collaboration ...
(Date:5/16/2013)... May 16, 2013  Today, the National Patient Advocate ... House of Representatives recently approved a bill that ... charging patients higher out-of-pocket fees for newer, more expensive ... which have more severe side-effects. However, the bill was ... which will continue to be a barrier to patients ...
(Date:5/16/2013)... 2013  Amgen (NASDAQ: AMGN ) will participate ... 21, 2013, at the Sheraton New York Times Square in ... a.m. Eastern Daylight Time. Joseph P. Miletich ... at Amgen, will present at the conference. Live audio of ... Amgen,s website, www.amgen.com , under Investors. A replay of ...
Breaking Medicine Technology:AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 2AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 3AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 4AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 5AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 6National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 2National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 3
... Inc. (Nasdaq: VRUS ) and Bristol-Myers Squibb ... addition of four treatment arms to the ongoing Phase ... nucleotide polymerase inhibitor, and Bristol-Myers Squibb Company,s daclatasvir (BMS-790052), ... of chronic hepatitis C (HCV).  This trial is the ...
... of the recent Centers for Disease Control and Prevention (CDC) ... the physician leadership of the American Academy of Pain Medicine ... Safe Opioid Prescribing: Reversing the Trends. Debuting as ... CA, in February 2012, the Safe Opioid Prescribing program is ...
Cached Medicine Technology:New 12 Week, Interferon-Free Treatment Arms Added to All-Oral Combination Study of PSI-7977 and Daclatasvir (BMS-790052) for HCV Genotype 1 2New 12 Week, Interferon-Free Treatment Arms Added to All-Oral Combination Study of PSI-7977 and Daclatasvir (BMS-790052) for HCV Genotype 1 3New 12 Week, Interferon-Free Treatment Arms Added to All-Oral Combination Study of PSI-7977 and Daclatasvir (BMS-790052) for HCV Genotype 1 4New 12 Week, Interferon-Free Treatment Arms Added to All-Oral Combination Study of PSI-7977 and Daclatasvir (BMS-790052) for HCV Genotype 1 5Academy of Pain Medicine Announces Two-Day Course for Safe Prescribing for Your Primary Physician 2Academy of Pain Medicine Announces Two-Day Course for Safe Prescribing for Your Primary Physician 3
(Date:5/19/2013)... At a May 6th, 2013 meeting ... Physicians (NCAPIP), the Pacific Chronic Disease Coalition (PCDC), ... Disease Directors (NACDD), presented a newly published assessment ... non-communicable diseases (NCDs) in the U.S. Associated Pacific ... Hawaii Journal of Medicine and Public Health, highlights ...
(Date:5/19/2013)... 19 (HealthDay News) -- Although spring arrived late this ... allergy season will still be strong, according to a ... Dr. Richard Waguespack, clinical professor in the university,s ... in a robust summer allergy season. However, some simple ... wheezing and coughing, he added. "Tree pollen has ...
(Date:5/19/2013)... ─ Gourmands and foodies everywhere have long recognized ginger ... zing to both sweet and savory dishes; now, a ... of the spicy root also may have properties that ... of the study will be presented at the ATS ... a tightening of the bronchial tubes that carry air ...
(Date:5/19/2013)... MO (PRWEB) May 19, 2013 Healthcare ... May 19-22, 2013, at the Walt Disney World Swan ... trends in supply chain innovation, care delivery and healthcare ... different dynamic in all healthcare markets, with ... of the conversation,” said Todd Ebert, Amerinet president and ...
(Date:5/19/2013)... May 19, 2013 People in Minnesota have ... Altman Fitness is offering its 28 Day Fat Loss Formula. ... from the comfort of their own home. The product sells ... More information can be accessed here: http://altmanfitness.com/28-day-fat-loss-formula/ , ... leave their houses now, but after using the 28 Day ...
Breaking Medicine News(10 mins):Health News:Pacific Island Public Health Group Declares Diabetes at Pandemic Proportions 2Health News:Pacific Island Public Health Group Declares Diabetes at Pandemic Proportions 3Health News:Managing Seasonal Allergies 2Health News:Ginger compounds may be effective in treating asthma symptoms 2Health News:Healthcare Leaders Gather at 2013 Amerinet Member Conference to Share New Ways to Reduce Costs and Enhance Care Delivery 2
... downfall. Unlike women, who are born with a finite number of ... Study//, compiled by Norwich Union Healthcare, nearly one in 10 men ... have an effect on male fertility are traffic pollution, laptops, mobile ... food and driving. , ...
... wishes to diminish the risk to heart - a ... heavy and intense exercise. This was revealed by a ... clinical trial was conducted // and researchers found that ... 12 miles provided significant improvements in fitness levels and ...
... Finpro’s global industry team said that Telemedicine and biotechnology ... Finland and India.// Ms. Heikela talked to a gathering ... Confederation of Indian Industry (CII). ,Heikela said ... was exported mostly to other European nations. As part ...
... is a near-pandemic condition that threatens millions with loss ... of atherosclerotic plaque in the arteries outside your heart.// ... damaged blood vessels and grow new ones thus restoring ... ,TheraVitae, Ltd, a private, multinational company focuses on using ...
... has reported that the survival rate of women with breast ... cancer prior to 10 years//. The experts feel that the ... wide awareness for early detection of breast cancer and also ... research in the field of cancer. ,Professor Michel ...
... Diabetes mellitus is an independent risk factor for cardiovascular ... risk by 2-6 fold relative to nondiabetic subjects and ... patients will die of an atherosclerotic event//. ... for cardiovascular disease, and so the presence of even ...
Cached Medicine News:Health News:Incorrect lifestyle may be the cause of male infertility 2Health News:Enjoy Moderate Exercise and Keep Your Heart Fit 2Health News:Breast cancer women has shown an increase in survival rates 2
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
... Featured Products are kept ... and are offered as ... regular or extra long ... with insulation, flush ports, ...
... offered as 1-piece or modular, in regular ... may be customized with handles of choice ... and flush ports. Many standard patterns are ... affect delivery times. , Please Note: ...
... 5mm AEM Laparoscopic Instruments incorporate a layered ... are shielded and monitored to prevent stray ... instrument caused by insulation failure or capacitive ... protective shield built into all AEM Instruments ...
Medicine Products: